𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of enzyme immunoassay with radioimmunoassay for the detection of antibody to hepatitis B core antigen as the only marker of hepatitis b infection in a population with a high prevalence of hepatitis B

✍ Scribed by Dr. Alan J. Parkinson; Brian J. McMahon; David Hall; Donald Ritter; Mary Anne Fitzgerald

Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
529 KB
Volume
30
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Enzyme immunoassay (EIA) and radioimmunoassay (RIA) for the detection of antibody to hepatitis B core antigen (anti‐HBc) were compared using serum specimens from Alaska Natives screened during a hepatitis B control program that were initially positive by EIA for only anti‐HBc. Of 36 specimens from persons previously HBsAg positive but who were now only anti‐HBc positive by EIA, 94.4% were anti‐HBc positive by both assays, with anti‐HBc levels exceeding 93% inhibition. Low‐level antibody to hepatitis B surface antigen (anti‐HBs) (<10 SRU) and antibody to hepatitis Be (anti‐HBe) were also present in 50% and 48% of specimens positive for anti‐HBc, respectively. Of 148 specimens from persons initially positive for only anti‐HBc by EIA who had no previous documentation of any hepatitis B virus (HBV) infection, 64.5% were positive by repeat testing for anti‐HBc by both assays, and anti‐HBc levels in this sample exceeded 70% in 91.6% and 80.2% of specimens by EIA and RIA, respectively. Low‐level anti‐HBs and anti‐HBe were present in 45.8% and 15.6%, respectively. EIA detection of anti‐HBc was found to be less specific than RIA. Of specimens positive for anti‐HBc by EIA, 14.8% were negative by RIA. The specificity of the EIA could be improved with respect to RIA by increasing the cut‐off from 48% to 68%. In samples with lowlevel anti‐HBc (≧70% inhibition) as measured by either method, the anti‐HBc results was less likely to persist upon retesting, whereas sample with anti‐HBc levels of >70% inhibition the anti‐HBc was a reproducible finding frequently accompanied by either low‐level anti‐HBs or anti‐HBe.

📜 SIMILAR VOLUMES

Significance of isolated hepatitis B cor
Significance of isolated hepatitis B core antibodies detected by enzyme immunoassay in a high risk population
✍ Dr. A. C. M. Kroes; W. G. V. Quint; R. A. Heijtink 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB

## Abstract Serum samples, which were found positive for anti‐HBc and negative for HBsAg and anti‐HBs during routine testing with Abbott enzyme immunoassays (EIA), were collected prospectively. The samples were obtained from patients with a high risk of hepatitis B. Further analysis was carried out

The detection in urine specimens of IgG
The detection in urine specimens of IgG and IgM antibodies to hepatitis A and hepatitis B core antigens
✍ Mr. Keith R. Perry; John V. Parry; Elise M. Vandervelde; Philip P. Mortimer 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 545 KB

## Abstract The use of urine as a noninvasive specimen for the diagnosis of hepatitis A (HAV) and hepatitis B (HBV) virus infections was investigated. Specimens of urine were collected at the same time as blood or saliva specimens, or singly in cases of previously serologically confirmed recent inf

Development of a hepatitis delta virus a
Development of a hepatitis delta virus antibody assay for study of the prevalence of HDV among individuals infected with hepatitis B virus in China
✍ Liping Shen; Ying Gu; Le Sun; Yingchao Yang; Feng Wang; Yimin Li; Shengli Bi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

## Abstract Co‐infection with hepatitis delta virus (HDV) and hepatitis B virus (HBV) has been shown to be associated with a more severe form of acute and chronic hepatitis. Cloning and expression of recombinant HDV antigen (rHDAg) in __Escherichiacoli__ are described. Using purified rHDAg, a cost‐

Immunoglobulin a antibody against hepati
Immunoglobulin a antibody against hepatitis B core antigen of polymeric and monomeric forms, as well as of IgA1 and IgA2 subclasses, in acute and chronic infection with hepatitis B virus
✍ Mikio Hikata; Katsumi Tachibana; Mitsunobu Imai; Shigeko Naito; Akira Oinuma; Fu 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 615 KB

Solid-phase radioimmunoassays using monoclonal antibodies were used to assay antibody to hepatitis B core antigen of immunoglobulin A class in terms of polymeric and monomeric forms, as well as of IgAl and IgA2 subclasses, in the serum of persons infected with hepatitis B virus. The level of wcretor

Detection of mutations in the enhancer 2
Detection of mutations in the enhancer 2/core promoter region of hepatitis B virus in patients with chronic hepatitis B virus infection: Comparison with mutations in precore and core regions in relation to clinical status
✍ Honda, Arata; Yokosuka, Osamu; Ehata, Toshiki; Tagawa, Masami; Imazeki, Fumio; S 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 3 views

To investigate the meaning of the mutations in the enhancer 2/core promoter (Enh2/CP) region of hepatitis B virus (HBV) during the chronic HBV infection, mutations were examined in the Enh2/ CP region (carboxyl half of X region) and their correlation with mutations in the precore and core regions in

A pretransplant infection with precore m
A pretransplant infection with precore mutants of hepatitis B virus does not influence the outcome of orthotopic liver transplantation in patients on high dose anti-hepatitis B virus surface antigen immunoprophylaxis
✍ U Naumann; U Protzer-Knolle; T Berg; K Leder; H Lobeck; W Bechstein; G Gerken; U 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 1 views

mines the outcome after OLT in patients on high dose HBIg Hepatitis B virus (HBV) infection of the liver graft is a major prophylaxis. (HEPATOLOGY 1997;26:478-484.) complication after orthotopic liver transplantation (OLT) for HBV-related cirrhosis. A high viral load before OLT is a known risk facto